eligibility for clinicaltrials:NCT00042861 [clinicaltrials_resource:e82d7f32f683b8f21974dfed4c82da9e]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00042861 [clinicaltrials_resource:e82d7f32f683b8f21974dfed4c82da9e]
Bio2RDF identifier
e82d7f32f683b8f21974dfed4c82da9e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e82d7f32f683b8f21974dfed4c82da9e
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
DISEASE CHARACTERISTICS:
...... urrent sorivudine or brivudine
identifier
clinicaltrials_resource:e82d7f32f683b8f21974dfed4c82da9e
title
eligibility for clinicaltrials:NCT00042861
@en
type
label
eligibility for clinicaltrials ...... d7f32f683b8f21974dfed4c82da9e]
@en